MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617053268 A) filed by Cansino Biologics Inc. on April 27, 2026, for Immune Composition Against Meningococcus And Use Thereof.
Inventors include Shi, Jianming; Zheng, Peng; Mo, Qingshan; Tao, Zhenmin; Zhang, Xuekuang; Tian, Wentan; Sui, Xiuwen; Deng, Jie; Xu, Qingfu; Shao, Zhongqi; and Zhu, Tao.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: Provided is an immunogenic composition comprising at least two antigens. Provided is a specific combination of Neisseria meningitidis antigens, which can significantly improve the efficacy of the immunogenic composition against Neisseria infection. The synergistic combination of the specific antigen combination is greater than the additive reaction triggered by the antigens alone. On the basis of epidemiological studies in China, the immunogenic composition targeting a broader coverage of MenB strains is developed.
Disclaimer: Curated by HT Syndication.
